Change of management in AquaGen

Rolf Nordmo (56) has been appointed as the new CEO of AquaGen. He comes from a position as CEO of ACD Pharmaceuticals, and will start in his new position in AquaGen on 1 January 2015. Nordmo is a trained veterinarian from the Norwegian College of Veterinary Medicine and started his professional career as a veterinary inspector in the Ministry of Agriculture. Later he led the establishment and subsequent operation of the research station VESO Vikan, Namsos for 12 years. The next 12 years he worked as managing director at Biotech AH & N, Immunocorp and Biorigin Scandinavia with the development and sale of immunostimulatory feed ingredients for fish and other animals. For the last four years in Biorigin, he also run the establishment and operation of the Brazilian-owned company Biorigin Europe in Antwerp, Belgium. Biorigin is a world leader in yeast based feed ingredients for animals. For the last 18 months Nordmo headed the company ACD Pharmaceuticals in Oslo. ACD is a company in the Nordly group that works with research and development towards the protection of fish from diseases. Espen Müller (52), who has led AquaGen since 2013, has decided to seek new challenges. He has been in different executive positions in the company over a period of 10 years and contributed to developing the company into a global leader in salmon breeding. The board would like to thank Müller for his efforts during these years, and wish him luck in his future career.